EXAGEN INC. - COMMON S

Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board

16 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum

09 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022

08 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

02 Feb 2022 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection

09 Jan 2022 11:00:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

17 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2021 Results

10 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

04 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

27 Oct 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

27 Oct 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces $27.2 Million Debt Refinancing

25 Oct 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

21 Oct 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

13 Sep 2021 15:15:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2021 Results

09 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Appoints Ana Hooker to Board of Directors

30 Jul 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

29 Jul 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021

26 Jul 2021 15:05:56 By Nasdaq GlobeNewswire

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

13 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Elects Frank Stokes to Board of Directors

18 Jun 2021 07:29:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

24 May 2021 15:05:00 By Nasdaq GlobeNewswire